Therapeutic Fc‐fusion proteins: current analytical strategies

BL Duivelshof, A Murisier, J Camperi… - Journal of separation …, 2021 - Wiley Online Library
Fc‐Fusion proteins represent a successful class of biopharmaceutical products, with already
13 drugs approved in the European Union and United States as well as three biosimilar …

Carbohydrate content of CTLA4 molecules

KJ Leister, EJ Schaefer, RC Bates… - US Patent …, 2020 - Google Patents
The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig
and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and …

Compositions and methods for producing a composition

KJ Leister, EJ Schaefer, RC Bates… - US Patent …, 2020 - Google Patents
The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig
and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and …

Carbohydrate content of CTLA4 molecules

KJ Leister, EJ Schaefer, RC Bates… - US Patent …, 2021 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
38218674&utm_source= google_patent&utm_medium= platform_link&utm_campaign …

[PDF][PDF] Fc-fusion proteins: therapeutic relevance and quality assessment

G Misini, N Dashor, R Petkovska… - Macedonian …, 2022 - academia.edu
Fc-fusion proteins are bioengineered polypeptides that combine a biologically active protein
with the crystallizable fragment (Fc) domain of an IgG to produce a molecule with unique …

Compositions and methods for producing a composition

KJ Leister, EJ Schaefer, RC Bates… - US Patent …, 2024 - Google Patents
2024-03-07 Assigned to BRISTOL-MYERS SQUIBB COMPANY reassignment BRISTOL-
MYERS SQUIBB COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …